{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:16:37Z","timestamp":1773922597627,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T00:00:00Z","timestamp":1317254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s13318-011-0063-8","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T19:40:37Z","timestamp":1317238837000},"page":"31-38","source":"Crossref","is-referenced-by-count":16,"title":["Pharmacokinetics of micafungin in HIV positive patients with confirmed esophageal candidiasis"],"prefix":"10.1007","volume":"37","author":[{"given":"N.","family":"Undre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Baraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,9,29]]},"reference":[{"issue":"10","key":"63_CR1","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1128\/AAC.00478-08","volume":"52","author":"DR Andes","year":"2008","unstructured":"Andes DR, Diekema DJ, Pfaller MA, Marchillo K, Bohrmueller J (2008) In vivo pharmacodynamic target investigation for micafungin against Candida albicans and C. glabrata in a neutropenic murine candidiasis model. Antimicrob Agents Chemother 52(10):3497\u20133503","journal-title":"Antimicrob Agents Chemother"},{"key":"63_CR2","unstructured":"Astellas Pharma GmbH (2008) Mycamine: summary of product characteristics [accessed 18 June 2009]"},{"issue":"6","key":"63_CR3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1378\/chest.110.6.1507","volume":"110","author":"G Barbaro","year":"1996","unstructured":"Barbaro G, Barbarini G, Di Lorenzo G (1996) Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group. Chest 110(6):1507\u20131514","journal-title":"Chest"},{"issue":"1","key":"63_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/clpt.2009.200","volume":"87","author":"DK Benjamin Jr","year":"2010","unstructured":"Benjamin DK Jr, Smith PB, Arrieta A, Castro L, S\u00e1nchez PJ, Kaufman D, Arnold LJ, Kovanda LL, Sawamoto T, Buell DN, Hope WW, Walsh TJ (2010) Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin Pharmacol Ther 87(1):93\u201399","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"63_CR5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1086\/423377","volume":"39","author":"N Wet de","year":"2004","unstructured":"de Wet N, Llanos-Cuentas A, Suleiman J, Baraldi E, Krantz EF, Della Negra M, Diekmann-Berndt H (2004) A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. Clin Infect Dis 39(6):842\u2013849","journal-title":"Clin Infect Dis"},{"key":"63_CR6","unstructured":"Freire A, Arrieta A, Stevenson P, Undre N (2007) Pharmacokinetics of Micafungin in pediatric patients with invasive candidiasis and candidemia. Paper presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, September 17\u201320, 2007"},{"issue":"3","key":"63_CR7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.01337-06","volume":"51","author":"T Gumbo","year":"2007","unstructured":"Gumbo T, Drusano GL, Liu W, Kulawy RW, Fregeau C, Hsu V, Louie A (2007) Once-weekly micafungin therapy is as effective as daily therapy for disseminated candidiasis in mice with persistent neutropenia. Antimicrob Agents Chemother 51(3):968\u2013974","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"63_CR8","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/0091270005279274","volume":"45","author":"MF Hebert","year":"2005","unstructured":"Hebert MF, Blough DK, Townsend RW, Allison M, Buell D, Keirns J, Bekersky I (2005a) Concomitant tacrolimus and micafungin pharmacokinetics in healthy volunteers. J Clin Pharmacol 45(9):1018\u20131024","journal-title":"J Clin Pharmacol"},{"issue":"10","key":"63_CR9","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1177\/0091270005279580","volume":"45","author":"MF Hebert","year":"2005","unstructured":"Hebert MF, Smith HE, Marbury TC, Swan SK, Smith WB, Townsend RW, Buell D, Keirns J, Bekersky I (2005b) Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction. J Clin Pharmacol 45(10):1145\u20131152","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"63_CR10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1128\/AAC.49.4.1331-1336.2005","volume":"49","author":"J Hiemenz","year":"2005","unstructured":"Hiemenz J, Cagnoni P, Simpson D, Devine S, Chao N, Keirns J, Lau W, Facklam D, Buell D (2005) Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant. Antimicrob Agents Chemother 49(4):1331\u20131336","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"63_CR11","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1086\/313843","volume":"30","author":"JE Kaplan","year":"2000","unstructured":"Kaplan JE, Hanson D, Dworkin MS, Frederick T, Bertolli J, Lindegren ML, Holmberg S, Jones JL (2000) Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 30(Suppl 1):S5\u2013S14","journal-title":"Clin Infect Dis"},{"issue":"RR-4","key":"63_CR12","first-page":"1","volume":"58","author":"JE Kaplan","year":"2009","unstructured":"Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58(RR-4):1\u2013207","journal-title":"MMWR Recomm Rep"},{"key":"63_CR13","unstructured":"Kuse E, Demeyer I, Stevenson P, N Undre N (2007a) Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidemia. Paper presented at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA, September 17\u201320, 2007"},{"issue":"9572","key":"63_CR14","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","volume":"369","author":"ER Kuse","year":"2007","unstructured":"Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA (2007b) Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet 369(9572):1519\u20131527","journal-title":"Lancet"},{"issue":"6","key":"63_CR15","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1128\/AAC.44.6.1728-1730.2000","volume":"44","author":"S Maesaki","year":"2000","unstructured":"Maesaki S, Hossain MA, Miyazaki Y, Tomono K, Tashiro T, Kohno S (2000) Efficacy of FK463, a (1, 3)-beta-d-glucan synthase inhibitor, in disseminated azole-resistant candida albicans infection in mice. Antimicrob Agents Chemother 44(6):1728\u20131730","journal-title":"Antimicrob Agents Chemother"},{"key":"63_CR16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1590\/S1413-86702007000600016","volume":"11","author":"R Manfredi","year":"2007","unstructured":"Manfredi R, Sabbatani S, Calza L (2007) Recurring Candida albicans esophagitis in a HIV-infected patient undergoing long-Term antiretroviral therapy, and with absent-negligible immunodeficiency. Brazilian J Infect Dis 11:605\u2013609","journal-title":"Brazilian J Infect Dis"},{"issue":"2","key":"63_CR17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1128\/JCM.44.2.324-326.2006","volume":"44","author":"SA Messer","year":"2006","unstructured":"Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA (2006) Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. J Clin Microbiol 44(2):324\u2013326","journal-title":"J Clin Microbiol"},{"issue":"7","key":"63_CR18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","volume":"45","author":"PG Pappas","year":"2007","unstructured":"Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN (2007) Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 45(7):883\u2013893","journal-title":"Clin Infect Dis"},{"issue":"1","key":"63_CR19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JCM.01901-07","volume":"46","author":"MA Pfaller","year":"2008","unstructured":"Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ (2008) In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. J Clin Microbiol 46(1):150\u2013156","journal-title":"J Clin Microbiol"},{"issue":"2","key":"63_CR20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF03191129","volume":"31","author":"K Tabata","year":"2006","unstructured":"Tabata K, Katashima M, Kawamura A, Kagayama A, Kohno S (2006a) Pharmacokinetics-pharmacodynamics of micafungin in Japanese patients with deep-seated mycosis. Eur J Drug Metab Pharmacokinet 31(2):123\u2013128","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"8","key":"63_CR21","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1248\/bpb.29.1706","volume":"29","author":"K Tabata","year":"2006","unstructured":"Tabata K, Katashima M, Kawamura A, Tanigawara Y, Sunagawa K (2006b) Linear pharmacokinetics of micafungin and its active metabolites in Japanese pediatric patients with fungal infections. Biol Pharm Bull 29(8):1706\u20131711","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"63_CR22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1185\/030079908X253401","volume":"24","author":"KB Tong","year":"2008","unstructured":"Tong KB, Murtagh KN, Lau C, Seifeldin R (2008) The impact of esophageal candidiasis on hospital charges and costs across patient subgroups. Curr Med Res Opin 24(1):167\u2013174","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"63_CR23","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/jac\/dkf247","volume":"50","author":"PA Warn","year":"2002","unstructured":"Warn PA, Sharp A, Morrissey G, Denning DW (2002) In vivo activity of micafungin in a persistently neutropenic murine model of disseminated infection caused by Candida tropicalis. J Antimicrob Chemother 50(6):1071\u20131074","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"63_CR24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3748\/wjg.15.1050","volume":"15","author":"AL Werneck-Silva","year":"2009","unstructured":"Werneck-Silva AL, Prado IB (2009) Role of upper endoscopy in diagnosing opportunistic infections in human immunodeficiency virus-infected patients. World J Gastroenterol 15(9):1050\u20131056","journal-title":"World J Gastroenterol"},{"key":"63_CR25","unstructured":"Yamato Y, Kaneko H, Tanimoto K, Katashima M, Ishibashi K, Kawamura A, Terakawa M, Kagayama A (2002) Simultaneous determination of antifungal drug, micafungin, and its two active metabolites in human plasma using high-performance liquid chromatography with fluorescence detection. Jpn J Chemother 50 (Suppl 1):68\u201373"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-011-0063-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-011-0063-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-011-0063-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:44:32Z","timestamp":1559490272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-011-0063-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["63"],"URL":"https:\/\/doi.org\/10.1007\/s13318-011-0063-8","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,29]]}}}